ApprovalTrail

Approval · Notice of Compliance 4369 · 1996

DYNABAC: Notice of Compliance 4369

Issued October 28, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4369
Date
October 28, 1996
Company
Eli Lilly Canada IncToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
DYNABAC02229863—

Medicinal ingredients